𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B

✍ Scribed by Vicente Carreño; Stefan Zeuzem; Uwe Hopf; Patrick Marcellin; W.Graham E. Cooksley; Johan Fevery; Moisés Diago; Rajender Reddy; Marion Peters; Karen Rittweger; Ashok Rakhit; Margarita Pardo

Book ID
119525553
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
936 KB
Volume
32
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiviral effect of human recombinant in
Antiviral effect of human recombinant interleukin-12 in patients infected with hepatitis C virus
✍ Lee, Jung-Hun; Teuber, Gerlinde; von Wagner, Michael; Roth, Willi Kurt; Zeuzem, 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB 👁 2 views

The heterogeneity of hepatitis C virus (HCV) is due to the continuous and high replication rate, the low fidelity of the RNA-dependent RNA polymerase, and the immune surveillance of the host. Interleukin-12 (IL-12) plays a central role in mounting an effective cellular immune response directed towar

A phase II dose-escalating trial of clev
A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B
✍ Patrick Marcellin; Herve Mommeja-Marin; Stephen L. Sacks; George K. K. Lau; Dani 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

Current therapies available for the treatment of chronic hepatitis B are limited in their ability to result in a cure. Clevudine is a new pyrimidine analog with potent anti-hepatitis B virus (HBV) activity in vitro. A multicenter dose-escalation study evaluated clevudine at 10, 50, 100, and 200 mg o